Quick departure for Semerjian as Immunomedics CEO; plus Ziopharm, Kinnate, Applied Therapeutics, Relmada, AskBio and more

By Robin Sawka, BioCentury Staff | May 28, 2020 | 1:20 AM GMT

Less than two months after becoming president and CEO of Immunomedics Inc. (NASDAQ:IMMU), Harout Semerjian is stepping down because of “unfortunate significant logistical obstacles presented by the COVID-19 pandemic,” according to the cancer company. Executive Chairman Behzad Aghazadeh will continue to help lead the company,

Read the full 458 word article

How to gain access

Continue reading with a
two-week free trial.